目的研究微小RNA-146a(miR-146a)对高糖诱导的人视网膜内皮细胞炎症反应的调控作用及其机制。
方法收集2013年10—12月在南京医科大学附属无锡人民医院就诊的单纯糖尿病患者57例和糖尿病视网膜病变(DR)患者40例。另选取41名健康者作为正常对照。收集受检者的一般检查结果,并采集受检者静脉抗凝血各5 ml。体外培养人视网膜内皮细胞(HREC)系,分为高糖组和正常对照组,分别采用含30 mmol/L葡萄糖的DMEM培养液和正常DMEM培养液培养。采用荧光定量PCR法分别检测各组受检者外周血和体外培养HREC中miR-146a的表达水平。分别用lipofectamine2000装载50 nmol/L miR-146a模拟物、模拟物对照剂和miR-146a抑制物、抑制物对照剂转染HREC。采用荧光定量PCR法检测各转染组细胞中miR-146a和细胞间黏附分子-1(ICAM-1)mRNA的表达水平。采用Western blot法检测核因子кB(NF-кB)p65和NF-кB p65 Ser536蛋白相对表达量。
结果糖尿病组和DR组miR-146a相对表达量分别为0.36±0.08和0.27±0.08,明显低于正常对照组的1.00±0.16,差异均有统计学意义(均 P<0.01)。在高糖组HREC细胞中miR-146a相对表达量为0.37±0.11,明显低于正常对照组的1.00±0.18,差异有统计学意义( t=5.57, P<0.01)。miR-146a模拟物组miR-146a mRNA的相对表达量为2 540.00±105.00,明显高于模拟物对照组的61.00±17.90;miR-146a抑制物组miR-146a mRNA的相对表达量为0.04±0.01,明显低于抑制物对照组的0.88±0.04,差异均有统计学意义( t=23.23、17.12,均 P<0.01)。miR-146a模拟物组ICAM-1 mRNA的相对表达量为0.35±0.12,明显低于模拟物对照组的1.00±0.13;miR-146a抑制物组ICAM-1 mRNA的相对表达量为2.74±0.48,明显高于抑制物对照组的1.00±0.16,差异均有统计学意义( t=3.58、3.37,均 P<0.05)。miR-146a模拟物组NF-кB p65 Ser536蛋白相对表达量为0.43±0.03,明显低于模拟物对照组的1.07±0.09,差异有统计学意义( t=6.74, P<0.01)。miR-146a抑制物组NF-кB p65 Ser536蛋白相对表达量为2.08±0.12,明显高于抑制物对照组的1.00±0.01,差异有统计学意义( t=8.76, P<0.01)。
结论miR-146a能够通过抑制NF-кB磷酸化水平和ICAM-1的表达,减轻DR的炎症反应。
ObjectiveTo observe the effects of miR-146a on human retinal endothelial cell (HREC) under high glucose condition.
MethodsTotal of 57 cases diagnosed as diabetic mellitus and 40 cases with diabetic retinopathy (DR) in Wuxi People's Hospital Affiliated to Nanjing Medical University from October to December 2013.Forty-one healthy volunteers were enrolled and served as control group.The clinical data and venous blood samples of subjects were collected.HRECs were cultured in normal glucose (5.5 mmol/L) or high glucose medium (30 mmol/L). Real-time PCR was used to detect the expression of miR-146a.The cultured HRECs were transfected with miR-146a mimic, mimic negative control, inhibitor and inhibitor negative control by lipofectamine2000, respectively.The expression of miR-146a and intercellular cell adhesion molecule-1 (ICAM-1) mRNA was examined by real-time PCR and the expression of nuclear factor-кB (NF-кB) p65 and NF-кB p65 Ser536 was detected by Western blot assay.
ResultsThe relative expression of miR-146a mRNA in the diabetic mellitus group and DR group was 0.36±0.08 and 0.27±0.08, respectively, which were significantly lower than 1.00±0.16 in the control group (both at P<0.01). The expression of miR-146a mRNA was 0.37±0.11 in the high glucose group, which was lower than 1.00±0.18 in the normal control group ( t=5.57, P<0.01). The relative expression of miR-146a mRNA in the miR-146a mimic group was 2 540.00±105.00, which was significantly higher than 61.00±17.90 in the miR-146a mimic control group; The relative expression of miR-146a mRNA in the miR-146a inhibitor group was 0.04±0.01, which was significantly lower than 0.88±0.04 in the miR-146a inhibitor control group ( t=23.23, 17.12; both at P<0.01). The relative expression of ICAM-1 mRNA in the miR-146a mimic group was 0.35±0.12, which was significantly lower than 1.00±0.13 in the miR-146a mimic control group; The relative expression of ICAM-1 mRNA in the miR-146a inhibitor group was 2.74±0.48, which was significantly higher than 1.00±0.16 in the miR-146a inhibitor control group ( t=3.58, 3.37; both at P<0.05). The relative expression of NF-кB p65 Ser536 in the miR-146a mimic group was 0.43±0.03, which was significantly lower than 1.07±0.09 in the miR-146a mimic control group ( t=6.74, P<0.01). The relative expression of NF-кB p65 Ser536 in the miR-146a inhibitor group was 2.08±0.12, which was significantly higher than 1.00±0.01 in the miR-146a inhibitor control group ( t=8.76; P<0.01).
ConclusionsmiR-146a can reduce inflammation of HREC in high glucose condition through inhibiting ICAM-1 expression and NF-кB phosphorylation.
顾顺,詹鹏飞,王文娟,等. miR-146a对糖尿病视网膜病变炎症反应的抑制作用[J]. 中华实验眼科杂志,2020,38(09):733-739.
DOI:10.3760/cma.j.cn115989-20190213-00051版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。